Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 20084109)

1.

Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.

Blehaut H, Mircher C, Ravel A, Conte M, de Portzamparc V, Poret G, de Kermadec FH, Rethore MO, Sturtz FG.

PLoS One. 2010 Jan 11;5(1):e8394. doi: 10.1371/journal.pone.0008394.

2.

Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial.

Ellis JM, Tan HK, Gilbert RE, Muller DP, Henley W, Moy R, Pumphrey R, Ani C, Davies S, Edwards V, Green H, Salt A, Logan S.

BMJ. 2008 Mar 15;336(7644):594-7. doi: 10.1136/bmj.39465.544028.AE. Epub 2008 Feb 21.

3.

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.

van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ, Westgeest TA, Romme TC, de Rooij DJ, Jacobs MJ, de Boo TM, van der Wilt GJ, Severens JL, Hartman M, Krabbe PF, Dijkmans BA, Breedveld FC, van de Putte LB.

Arthritis Rheum. 2001 Jul;44(7):1515-24.

4.

Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis.

Meyerovitch J, Antebi F, Greenberg-Dotan S, Bar-Tal O, Hochberg Z.

Arch Dis Child. 2012 Jul;97(7):595-8. doi: 10.1136/archdischild-2011-300806. Epub 2012 Apr 25.

PMID:
22535238
5.

Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.

Rheumatology (Oxford). 2002 Jun;41(6):658-65.

6.

Thyroid functions in children with Down's syndrome.

Unachak K, Tanpaiboon P, Pongprot Y, Sittivangkul R, Silvilairat S, Dejkhamron P, Sudasna J.

J Med Assoc Thai. 2008 Jan;91(1):56-61.

PMID:
18386545
7.

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.

Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C; MEADOWS trial researchers.

Lancet. 2012 Feb 11;379(9815):528-36. doi: 10.1016/S0140-6736(11)61676-0. Epub 2012 Jan 10.

PMID:
22236802
8.

Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity.

Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Annerén G.

Arch Dis Child. 1998 Sep;79(3):242-5.

9.

Studies of the thyroid function in children with Down's syndrome.

Schmidt BJ, Carvalho N, Ortega CC, Libermam J, Biazzi JM, Tapajós PM, Krynski S.

Arq Neuropsiquiatr. 1975 Mar;33(1):21-4.

PMID:
51614
10.

Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.

J Nephrol. 2003 Jul-Aug;16(4):522-34.

PMID:
14696754
11.

Lexical and syntactic development in Italian children with Down's syndrome.

Zampini L, D'Odorico L.

Int J Lang Commun Disord. 2011 Jul-Aug;46(4):386-96. doi: 10.3109/13682822.2010.508764. Epub 2011 May 27.

PMID:
21771215
12.
13.

Development of Down's syndrome infants with and without heart defects and changes in their caretaking environment.

Barrera ME, Watson LJ, Adelstein A.

Child Care Health Dev. 1987 Mar-Apr;13(2):87-100.

PMID:
2953506
14.

Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency.

Licastro F, Mariani RA, Faldella G, Carpenè E, Guidicini G, Rangoni A, Grilli T, Bazzocchi G.

Brain Res Bull. 2001 May 15;55(2):313-7.

PMID:
11470333
15.

Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.

Dördelmann M, Schrappe M, Reiter A, Zimmermann M, Graf N, Schott G, Lampert F, Harbott J, Niemeyer C, Ritter J, Dörffel W, Nessler G, Kühl J, Riehm H.

Leukemia. 1998 May;12(5):645-51.

PMID:
9593260
16.

Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.

Hagebeuk EE, Duran M, Koelman JH, Abeling NG, Vyth A, Poll-The BT.

J Child Neurol. 2012 Mar;27(3):304-9. doi: 10.1177/0883073811417184. Epub 2011 Aug 24.

PMID:
21868372
17.

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.

Connelly PJ, Prentice NP, Cousland G, Bonham J.

Int J Geriatr Psychiatry. 2008 Feb;23(2):155-60.

PMID:
17600848
18.

Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development.

Annerén G, Tuvemo T, Carlsson-Skwirut C, Lönnerholm T, Bang P, Sara VR, Gustafsson J.

Arch Dis Child. 1999 Apr;80(4):334-8.

19.

Prophylaxis of folate deficiency in acutely ill patients: results of a randomized clinical trial.

Campillo B, Zittoun J, de Gialluly E.

Intensive Care Med. 1988;14(6):640-5.

PMID:
3141491
20.

Substantial reduction in severe diarrheal morbidity by daily zinc supplementation in young north Indian children.

Bhandari N, Bahl R, Taneja S, Strand T, Mølbak K, Ulvik RJ, Sommerfelt H, Bhan MK.

Pediatrics. 2002 Jun;109(6):e86.

PMID:
12042580
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk